{"id":839021,"date":"2025-04-17T21:06:02","date_gmt":"2025-04-18T01:06:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/"},"modified":"2025-04-17T21:06:02","modified_gmt":"2025-04-18T01:06:02","slug":"kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/","title":{"rendered":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122"},"content":{"rendered":"

<\/p>\n

KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122<\/b><\/p>\n

–(BUSINESS WIRE<\/a>)–
\nAditxt, Inc. requests that their press release NewsItemId: 20250417385764 \u201cDr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\u201d be killed.\n<\/p>\n

\nThe release was issued in error by Aditxt, Inc..\n<\/p>\n

\nA replacement release will not be issued at this time.\n<\/p>\n

Aditxt, Inc.
\n<\/span><\/b>
Corporate Communications
\n
Jeff Ramson, PCG Advisory, Inc.
\n
T: 646-863-6893
\n
contactus@aditxt.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Science Neurology Biotechnology Research Pharmaceutical Health Genetics Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 –(BUSINESS WIRE)– Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 \u201cDr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\u201d be killed. The release was issued in error by Aditxt, Inc.. A replacement release will not be issued at this time. Aditxt, Inc. Corporate Communications Jeff Ramson, PCG Advisory, Inc. T: 646-863-6893 contactus@aditxt.com KEYWORDS: United States North America California INDUSTRY KEYWORDS: Science Neurology Biotechnology Research Pharmaceutical Health Genetics … <\/p>\n

Continue reading “KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839021","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 –(BUSINESS WIRE)– Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 \u201cDr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\u201d be killed. The release was issued in error by Aditxt, Inc.. A replacement release will not be issued at this time. Aditxt, Inc. Corporate Communications Jeff Ramson, PCG Advisory, Inc. T: 646-863-6893 contactus@aditxt.com KEYWORDS: United States North America California INDUSTRY KEYWORDS: Science Neurology Biotechnology Research Pharmaceutical Health Genetics … Continue reading "KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-18T01:06:02+00:00\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\",\"datePublished\":\"2025-04-18T01:06:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/\"},\"wordCount\":158,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/\",\"name\":\"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"datePublished\":\"2025-04-18T01:06:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/","og_locale":"en_US","og_type":"article","og_title":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk","og_description":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 –(BUSINESS WIRE)– Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 \u201cDr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\u201d be killed. The release was issued in error by Aditxt, Inc.. A replacement release will not be issued at this time. Aditxt, Inc. Corporate Communications Jeff Ramson, PCG Advisory, Inc. T: 646-863-6893 contactus@aditxt.com KEYWORDS: United States North America California INDUSTRY KEYWORDS: Science Neurology Biotechnology Research Pharmaceutical Health Genetics … Continue reading \"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-18T01:06:02+00:00","author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122","datePublished":"2025-04-18T01:06:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/"},"wordCount":158,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/","name":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"datePublished":"2025-04-18T01:06:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kill-dr-charles-howe-of-the-mayo-clinics-neuroimmunology-department-to-join-aditxt-weekly-update-on-may-2-2025-to-discuss-newly-announced-preclinical-study-results-sponsored-by-aditxt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"KILL Dr. Charles Howe of the Mayo Clinic\u2019s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt\u2019s Subsidiary Adimune\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839021"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839021\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}